DK0958351T3 - Chimere målmolekyler med regulerbar aktivitet - Google Patents

Chimere målmolekyler med regulerbar aktivitet

Info

Publication number
DK0958351T3
DK0958351T3 DK97952131.7T DK97952131T DK0958351T3 DK 0958351 T3 DK0958351 T3 DK 0958351T3 DK 97952131 T DK97952131 T DK 97952131T DK 0958351 T3 DK0958351 T3 DK 0958351T3
Authority
DK
Denmark
Prior art keywords
molecule
binding molecule
chimeric
activity
binding
Prior art date
Application number
DK97952131.7T
Other languages
English (en)
Inventor
Daniel Legendre
Patrice Soumillion
Jacques Fastrez
Original Assignee
Univ Catholique Louvain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25047774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0958351(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Catholique Louvain filed Critical Univ Catholique Louvain
Application granted granted Critical
Publication of DK0958351T3 publication Critical patent/DK0958351T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/02—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
    • C12Y305/02006—Beta-lactamase (3.5.2.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
DK97952131.7T 1996-11-27 1997-11-26 Chimere målmolekyler med regulerbar aktivitet DK0958351T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/757,425 US6500660B1 (en) 1996-11-27 1996-11-27 Chimeric target molecules having a regulatable activity
PCT/IB1997/001643 WO1998023731A2 (en) 1996-11-27 1997-11-26 Chimeric target molecules having a regulatable activity

Publications (1)

Publication Number Publication Date
DK0958351T3 true DK0958351T3 (da) 2010-03-15

Family

ID=25047774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97952131.7T DK0958351T3 (da) 1996-11-27 1997-11-26 Chimere målmolekyler med regulerbar aktivitet

Country Status (10)

Country Link
US (1) US6500660B1 (da)
EP (1) EP0958351B1 (da)
JP (1) JP4416185B2 (da)
AT (1) ATE449166T1 (da)
AU (1) AU5571998A (da)
DE (1) DE69739664D1 (da)
DK (1) DK0958351T3 (da)
ES (1) ES2336634T3 (da)
PT (1) PT958351E (da)
WO (1) WO1998023731A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1349869A4 (en) * 2000-11-08 2007-12-12 Commw Scient Ind Res Org METHOD FOR IDENTIFYING ANTIBACTERIAL COMPOUNDS
US7705120B2 (en) 2001-06-21 2010-04-27 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
KR100428998B1 (ko) * 2001-09-10 2004-04-28 한국과학기술원 모체 단백질과는 크기와 서열이 다른 단백질의 변이집단을생산하는 방법
GB0209878D0 (en) * 2002-04-30 2002-06-05 Glaxosmithkline Biolog Sa Vaccine
EP2297207B1 (en) * 2008-06-19 2018-10-03 Prothix BV Use of anti-factor xi antibodies for prevention or treatment of thrombus formation
DE102022000897A1 (de) 2022-03-15 2023-09-21 Ruhr-Universität Bochum, Körperschaft des öffentlichen Rechts Implantierbarer Biosensor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002757A1 (en) * 1986-10-17 1988-04-21 Saramane Pty. Ltd.; Hybrid proteins or polypeptides
EP0397834B1 (en) * 1988-10-28 2000-02-02 Genentech, Inc. Method for identifying active domains and amino acid residues in polypeptides and hormone variants
WO1992007090A1 (en) * 1990-10-22 1992-04-30 Genentech, Inc. Methods for modifying and detecting the effects on the interaction of modified polypeptides and target substrates
AU4238893A (en) * 1992-05-07 1993-11-29 Regents Of The University Of California, The Novel diphtheria toxin-based molecules
US5674681A (en) * 1994-12-06 1997-10-07 Rothenberg; Barry E. Methods to identify hemochromatosis

Also Published As

Publication number Publication date
DE69739664D1 (de) 2009-12-31
AU5571998A (en) 1998-06-22
WO1998023731A3 (en) 1998-11-12
PT958351E (pt) 2010-02-17
WO1998023731A2 (en) 1998-06-04
EP0958351B1 (en) 2009-11-18
US6500660B1 (en) 2002-12-31
ES2336634T3 (es) 2010-04-14
JP2001515346A (ja) 2001-09-18
JP4416185B2 (ja) 2010-02-17
ATE449166T1 (de) 2009-12-15
EP0958351A2 (en) 1999-11-24

Similar Documents

Publication Publication Date Title
DE69638269D1 (de) Hochaffine humane antikörper gegen tumorantigene
HK1010058A1 (en) Screening assay for the detection of dna-binding molecules
DE69835143D1 (de) Selektion von proteinen mittels rns-protein fusionen
WO1998035693A3 (en) Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
ATE386116T1 (de) Bindungsdomänen des serrate-proteins
MX9304363A (es) Metodo para enlace intracelular de moleculas blanco.
ATE267394T1 (de) Nachweis der krankheitsbedingten konformation eines proteins
DE69714654D1 (de) Verwendung von einem Metalloporphyrinkonjugat für den Nachweis biologischer Verbindungen
ATE555202T1 (de) Verfahren zur lieferung von rna-interferenz und verwendungen damit
DE69232309D1 (de) Weitgehend reine rezeptorartige, tgf-beta-1-bindende moleküle und deren verwendungen
DE69723860D1 (de) VERFAHREN ZUR BESTIMMUNG VON IgE
ATE245197T1 (de) Entwurf diskontinuierlicher sonden unter verwendung von hybritopemapping
AU7532501A (en) Method for increasing luminescence assay sensitivity
DE69738454D1 (de) Oligonukleotide welche spezifisch retrovirale nukleokapsid-proteine binden
DK0958351T3 (da) Chimere målmolekyler med regulerbar aktivitet
DE69919503D1 (de) Verfahren zur bestimmung eines analyten und kit dafür
WO2004069860A3 (en) Isg15-conjugated proteins
EA199800843A1 (ru) Компьютерный способ создания химических структур, имеющих общие функциональные характеристики
EA199900387A1 (ru) Полипептиды, содержащие домены протеина gax, участвующие в подавлении транскрипции и/или взаимодействующие с другими протеинами, соответствующие нуклеиновые кислоты и их применение
ATE269905T1 (de) Verfahren zur herstellung von proteinen in wirtszellen unter verwendung von chaperoninen
WO2003012102A3 (fr) Acides nucleiques codant des proteines a domaine hect
WO2001061001A3 (de) Neues zentralnervöses protein, das k+-ströme moduliert
ATE171545T1 (de) Verfahren zur bestimmung des lysingehaltes von samen
JP2002539457A5 (da)
WO2001066745A3 (en) Presenilin/crk binding polypeptides (pcbp) and methods of use thereof